Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• As DIY ‘loopers’ reinvent artificial pancreas, endocrinologists confront safety, liability concerns
• Beyond weight loss, ketogenic diet may show promise for diabetes, PCOS
• Nonprofit announces plans to deliver Loop as supported, FDA-regulated mobile app
• Pharmacists can assist with diabetes-related insurance, adherence issues Susan Weiner, MS, RDN, CDN, CDCES, FADCES
• Fluoroquinolone safety labeling changes: An opportunity for physicians to reassess their prescribing practices Debra E. Boxwell, PharmD
• Adrenal vein sampling may expose patients with primary aldosteronism to excess radiation
• Both high, low gestational weight gain influence childhood adiposity
• Diabetes prevalence reaches 9.7% of U.S. population in 2016 and 2017
• Early signs of fatty liver, subclinical heart disease found in children with metabolically healthy obesity
• EMPA-REG: Empagliflozin can add 4 years to life expectancy in diabetes with CVD
• FDA-cleared blood glucose monitors not always accurate
• GLP-1-related nausea associated with acid reflux medications
• Hepatitis C triples diabetes risk following kidney transplantation
• Levothyroxine fails to improve quality of life, thyroid-related symptoms in subclinical hypothyroidism
• Many seemingly healthy children show signs of metabolic syndrome
• Obesity may increase risk for colorectal cancer among women
• Subclinical hypothyroidism increases CVD risk
• Suicide, alcohol-related and accidental deaths higher in diabetes
• Use of medications associated with rising osteoporosis risk
• Bone turnover markers fail to predict hip fracture in postmenopausal women
• Dementia increases risk for death from hypoglycemia in older adults with diabetes
• HARMONY: Albiglutide reduces CV risk in adults with type 2 diabetes, CVD
• Interferential current viable alternative to vaginal estriol cream for painful sex symptoms
• Leading diabetes groups stress patient-centered care, new therapies in updated consensus report
• Lorcaserin reduces diabetes progression in high-risk adults with obesity, CVD
• Mindfulness may mediate menopause-related symptoms
• Sexual harassment, assault associated with poor CV, mental health in women